Literature DB >> 17010902

Tomotherapy and other innovative IMRT delivery systems.

John D Fenwick1, Wolfgang A Tomé, Emilie T Soisson, Minesh P Mehta, T Rock Mackie.   

Abstract

Fixed-field treatments, delivered using conventional clinical linear accelerators fitted with multileaf collimators, have rapidly become the standard form of intensity-modulated radiotherapy (IMRT). Several innovative nonstandard alternatives also exist, for which delivery and treatment planning systems are now commercially available. Three of these nonstandard IMRT approaches are reviewed here: tomotherapy, robotic linear accelerators (CyberKnife, Accuray Inc., Sunnyvale, CA), and standard linear accelerators modulated by jaws alone or by their jaws acting together with a tertiary beam-masking device. Rationales for the nonstandard IMRT approaches are discussed, and elements of their delivery system designs are briefly described. Differences between fixed-field IMRT dose distributions and the distributions that can be delivered by using the nonstandard technologies are outlined. Because conventional linear accelerators are finely honed machines, innovative design enhancement of one aspect of system performance often limits another facet of machine capability. Consequently the various delivery systems may prove optimal for different types of treatment, with specific machine designs excelling for disease sites with specific target volume and normal structure topologies. However it is likely that the delivery systems will be distinguished not just by the optimality of the dose distributions they deliver, but also by factors such as the efficiency of their treatment process, the integration of their onboard imaging systems into that process, and their ability to measure and minimize or compensate for target movement, including the effects of respiratory motion.

Mesh:

Year:  2006        PMID: 17010902     DOI: 10.1016/j.semradonc.2006.04.002

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  17 in total

Review 1.  Volumetric modulated arc therapy: a review of current literature and clinical use in practice.

Authors:  M Teoh; C H Clark; K Wood; S Whitaker; A Nisbet
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

Review 2.  PET-guided delineation of radiation therapy treatment volumes: a survey of image segmentation techniques.

Authors:  Habib Zaidi; Issam El Naqa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-25       Impact factor: 9.236

3.  On the radiobiological impact of metal artifacts in head-and-neck IMRT in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).

Authors:  Yusung Kim; Wolfgang A Tomé
Journal:  Med Biol Eng Comput       Date:  2007-06-16       Impact factor: 2.602

Review 4.  Radiation-induced bystander signalling in cancer therapy.

Authors:  Kevin M Prise; Joe M O'Sullivan
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

Review 5.  The radiation techniques of tomotherapy & intensity-modulated radiation therapy applied to lung cancer.

Authors:  Zhengfei Zhu; Xiaolong Fu
Journal:  Transl Lung Cancer Res       Date:  2015-06

6.  Current concepts on imaging in radiotherapy.

Authors:  Michela Lecchi; Piero Fossati; Federica Elisei; Roberto Orecchia; Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-31       Impact factor: 9.236

Review 7.  Past, present, and future of radiotherapy for the benefit of patients.

Authors:  Juliette Thariat; Jean-Michel Hannoun-Levi; Arthur Sun Myint; Te Vuong; Jean-Pierre Gérard
Journal:  Nat Rev Clin Oncol       Date:  2012-11-27       Impact factor: 66.675

8.  On the performances of Intensity Modulated Protons, RapidArc and Helical Tomotherapy for selected paediatric cases.

Authors:  Antonella Fogliata; Slav Yartsev; Giorgia Nicolini; Alessandro Clivio; Eugenio Vanetti; Rolf Wyttenbach; Glenn Bauman; Luca Cozzi
Journal:  Radiat Oncol       Date:  2009-01-14       Impact factor: 3.481

9.  Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.

Authors:  Noha Jastaniyah; Albert Murtha; Nadeem Pervez; Duc Le; Wilson Roa; Samir Patel; Marc Mackenzie; Dorcas Fulton; Colin Field; Sunita Ghosh; Gino Fallone; Bassam Abdulkarim
Journal:  Radiat Oncol       Date:  2013-02-20       Impact factor: 3.481

10.  Critical structure sparing in stereotactic ablative radiotherapy for central lung lesions: helical tomotherapy vs. volumetric modulated arc therapy.

Authors:  Alexander Chi; Pan Ma; Guishan Fu; Gerry Hobbs; James S Welsh; Nam P Nguyen; Si Young Jang; Jinrong Dai; Jing Jin; Ritsuko Komaki
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.